Cargando…

Upgraded nomograms for the prediction of complications and survival in patients with colorectal liver metastases treated with neoadjuvant chemotherapy followed by hepatic resection

BACKGROUND: To establish upgraded nomograms incorporating neoadjuvant chemotherapy (NAC)-related factors and preoperative testing markers to predict postoperative complications, progression-free survival (PFS) and overall survival (OS) in patients with colorectal liver metastases (CRLM). METHODS: Mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qichen, Mao, Rui, Zhao, Jianjun, Bi, Xinyu, Li, Zhiyu, Huang, Zhen, Zhang, Yefan, Zhou, Jianguo, Zhao, Hong, Cai, Jianqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940886/ https://www.ncbi.nlm.nih.gov/pubmed/33708892 http://dx.doi.org/10.21037/atm-20-3973

Ejemplares similares

What is the optimal number of neoadjuvant chemotherapy cycles for resectable colorectal liver oligometastases?
por: Chen, Qichen, et al.
Publicado: (2021)

From the completion of neoadjuvant chemotherapy to surgery for colorectal cancer liver metastasis: What is the optimal timing?
por: Chen, Qichen, et al.
Publicado: (2020)

Preoperative D-dimer and Gamma-Glutamyltranspeptidase Predict Major Complications and Survival in Colorectal Liver Metastases Patients After Resection()
por: Chen, Qichen, et al.
Publicado: (2019)

Impact of Postoperative Infectious Complications on Long-Term Outcomes for Patients Undergoing Simultaneous Resection for Colorectal Cancer Liver Metastases: A Propensity Score Matching Analysis
por: Chen, Qichen, et al.
Publicado: (2022)

Simultaneous hepatic resection benefits patients with synchronous colorectal cancer liver metastases
por: Li, Yuan, et al.
Publicado: (2016)

Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review
por: Wei, Zhewen, et al.
Publicado: (2022)

Preoperatively elevated RDW-SD and RDW-CV predict favorable survival in intrahepatic cholangiocarcinoma patients after curative resection
por: Li, Xingchen, et al.
Publicado: (2021)

Nomogram Incorporating Preoperative Testing Markers for the prediction of Early Recurrence for Colorectal Liver Metastases with Neoadjuvant Chemotherapy followed by Hepatectomy
por: Chen, Qichen, et al.
Publicado: (2022)

A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma
por: Li, Xingchen, et al.
Publicado: (2021)

Differences of intraoperative outcomes and postoperative complications between intrahepatic cholangiocarcinoma and colorectal liver metastasis in different surgical methods
por: Chen, Qichen, et al.
Publicado: (2021)

The combination of preoperative D-dimer and CA19-9 predicts lymph node metastasis and survival in intrahepatic cholangiocarcinoma patients after curative resection
por: Chen, Qichen, et al.
Publicado: (2020)

An elevated preoperative cholesterol-to-lymphocyte ratio predicts unfavourable outcomes in colorectal cancer liver metastasis patients receiving simultaneous resections: a retrospective study
por: Deng, Yiqiao, et al.
Publicado: (2023)

Systematic review of resecting primary tumor in MNETs patients with unresectable liver metastases
por: Guo, Jingfei, et al.
Publicado: (2016)

Prognostic significance of the preoperative alkaline phosphatase‑to‑albumin ratio in patients with hepatocellular carcinoma after hepatic resection
por: Wang, Yikai, et al.
Publicado: (2023)

The prognostic factors of primary colorectal sarcoma and the clinical outcomes of negative lymph node dissection
por: Wei, Zhewen, et al.
Publicado: (2021)

Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases
por: Zhu, Dexiang, et al.
Publicado: (2014)

Resection of colorectal liver metastases following neoadjuvant chemotherapy
por: Chiappa, A, et al.
Publicado: (2007)

Nomogram for tumour response based on prospective cohorts of hepatocellular carcinoma patients receiving immunotherapy combined with targeted therapy: development and validation
por: Chen, Qichen, et al.
Publicado: (2023)

Development of a Metastasis-Related Immune Prognostic Model of Metastatic Colorectal Cancer and Its Usefulness to Immunotherapy
por: Luo, Zhiwen, et al.
Publicado: (2021)

Prognosis of patients with hepatocellular carcinoma and hypersplenism after surgery: a single-center experience from the People’s Republic of China
por: Li, Cong, et al.
Publicado: (2014)

Should surgery be conducted for small nonfunctioning pancreatic neuroendocrine tumors: a systematic review
por: Guo, Jingfei, et al.
Publicado: (2017)

Clinical Analysis of 15 Cases of Gallbladder Neuroendocrine Carcinoma and Comparison with Gallbladder Adenocarcinoma Using a Propensity Score Matching
por: Yan, Shida, et al.
Publicado: (2020)

Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases
por: Ichida, Hirofumi, et al.
Publicado: (2019)

Nomogram predicting early recurrence defined by the minimum P value approach for colorectal liver metastasis patients receiving colorectal cancer resection with simultaneous liver metastasis resection: development and validation
por: Deng, Yiqiao, et al.
Publicado: (2023)

Is neoadjuvant chemotherapy necessary for patients with initially resectable colorectal liver metastases in the era of effective chemotherapy?
por: Son, Sang-Yong, et al.
Publicado: (2011)

CEA Level, Radical Surgery, CD56 and CgA Expression Are Prognostic Factors for Patients With Locoregional Gastrin-Independent GNET
por: Li, Yuan, et al.
Publicado: (2016)

Outcome of Microscopic Incomplete Resection (R1) of Colorectal Liver Metastases in the Era of Neoadjuvant Chemotherapy
por: Ayez, Ninos, et al.
Publicado: (2011)

The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis
por: Liu, Wei, et al.
Publicado: (2016)

Efficacy of neoadjuvant chemotherapy for initially resectable colorectal liver metastases: A retrospective cohort study
por: Takeda, Kazuhisa, et al.
Publicado: (2022)

Development and Validation of Prognostic Nomograms for Periampullary Neuroendocrine Neoplasms: A SEER Database Analysis
por: Chen, Jinghua, et al.
Publicado: (2022)

AST·MLR index and operation injury condition are novel prognostic predictor for the prediction of survival in patients with colorectal cancer liver metastases undergoing surgical resection
por: Chen, Qichen, et al.
Publicado: (2022)

Neoadjuvant chemotherapy for patients with resectable colorectal cancer liver metastases: A systematic review and meta-analysis
por: Zhang, Yue, et al.
Publicado: (2021)

Nomogram for Predicting Breast Conservation after Neoadjuvant Chemotherapy
por: Kim, Min Kyoon, et al.
Publicado: (2015)

Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases
por: Li, Rongzhen, et al.
Publicado: (2021)

Recent advances in the ARID family: focusing on roles in human cancer
por: Lin, Chen, et al.
Publicado: (2014)

Hepatic resection after neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer: need for cautious planning
por: Kim, Young Il, et al.
Publicado: (2019)

ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?
por: Flood, Michael P., et al.
Publicado: (2022)

Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers
por: Wang, Zhongyi, et al.
Publicado: (2021)

DCE-MRI radiomics nomogram can predict response to neoadjuvant chemotherapy in esophageal cancer
por: Qu, Jinrong, et al.
Publicado: (2022)

ARID2: A new tumor suppressor gene in hepatocellular carcinoma
por: Zhao, Hong, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rhsmnjvoa67pf4lsga6fjv2jgg